N
Google TrendSELMA BLAIR (2000+) — Selma Blair arrested for biting flight attendant, trying to open plane door
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:selma blair2000+al-nassr vs neftchi fergana2000+samantha busch500+peggy flanagan200+sean combs10000+boeing 747500+frank bisignano2000+justin watson500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Extending Aromatase-Inhib" (30 stories)

Top Headline Story

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
Lead StoryNEJMgeneral
Jun 5, 2016

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE84aW1sblNqR3hLWmY1OUhqb2ZMYjR4eHZ0SXFvS21lTmVhcEpMUzdJbDJJT2Vha3QxdEpwQk4ycndUbzVQVDZnWk1MaDduRGxyUFZld1ZwenBEcUlFRUZTRw?oc=5" target="_blank">Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
2000+32m ago

selma blair

Selma Blair arrested for biting flight attendant, trying to open plane door

Filter stories
2000+42m ago

al-nassr vs neftchi fergana

Al Nassr Asian Champions League clash in doubt over Riyadh security situation

Filter stories
500+42m ago

samantha busch

Kyle Busch’s Widow Samantha Calls His Death ‘Unfair’ After ‘Emotional’ Celebration for Beloved NASCAR Star

Filter stories
200+42m ago

peggy flanagan

Minnesota Poll: Flanagan holds narrow lead over Tafoya in U.S. Senate race

Filter stories

Search Results for "Extending Aromatase-Inhib"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Extending aromatase inhibitor treatment in early breast cancer; longer is better for many
The Lancetgeneral

Extending aromatase inhibitor treatment in early breast cancer; longer is better for many

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPYndLYmtNVDk5bUlseHRfTHFEc0kyaEZOZlg2Y1BMLVdTTWN5RlcxVFFqWF80MDFmbDkwMThGdzQ3UDg2UlVUQm5pUVVudG9fYTlrMzJBalFRWWhjNUZLdXMzWXJPQmNOSllSSENxdzdaNHNvLTNwUHJfWE1UU2dXQnM4V19GaEY1UFdB?oc=5" target="_blank">Extending aromatase inhibitor treatment in early breast cancer; longer is better for many</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women
2 Minute Medicinegeneral

Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNdlBlMjd5dXd2NVFsVGR6cjRaX19MZm56RHNzeWtHVTRXbkFTUk03T09pLU5yN1lRcVRPQlhuZlZxeWJyS0x2WUJ4b3F6dWRCZ2Y0TXNBaEZmenlVMElFb2lsUGdOZEpFY3ltY3hVMFN1dm9ucjU4c3Fuc2tBSXJUNGpidVBUVGJGRWFJS2NGX3Y5TFFmR0gzdHFXb2hTd2s1YUZyb3VZSlJnV3owNGZkLXZEZnhVTnZ2bWRRbVpSY1ZmMWhB?oc=5" target="_blank">Extended aromatase inhibitor therapy reduces breast cancer recurrence in postmenopausal women</a>  <font color="#6f6f6f">2 Minute Medicine</font>

Read Full StoryMore like this
Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer
National Cancer Institute (.gov)general

Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOaHJHc0l1T3Exd3FsRkZkeDhkRERJd3R1WGpmbUFYbnBvMHVNSkJGNmxfX2hWeVZRZ2V4emJUdnJyaHJBV3B0TVBhdlpOLTRrWTk3MTdNanBGVzllaXpqU3hlZ216eHhreS1oa2U2eV82MjNVU2FYYTNqUFBSUjJlMnUxRS1uLTVOb0Vjb1NaSQ?oc=5" target="_blank">Extended Adjuvant Therapy Beneficial for Some Women with Breast Cancer</a>  <font color="#6f6f6f">National Cancer Institute (.gov)</font>

Read Full StoryMore like this
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer
NEJMgeneral

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE4yVFByMUo1M1YxVElRTTR2QXpSeXdaMFpCRGF4YlI1OW9YXzJsejVuUUNiVUd1Ym94cTN5bzdRbmJET0tZMEtvRWcxSFNUQTdUMFA2c2hscWpXVmt5Qzhqbw?oc=5" target="_blank">Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
New Recommendations Released for Managing Aromatase Inhibitor–Induced Bone Loss
The ASCO Postgeneral

New Recommendations Released for Managing Aromatase Inhibitor–Induced Bone Loss

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQVllQSTA1U0VvTFZxUDV5NlZZMEFyWVBhV1hzOWhzcXNsNEU1Z3VOT2FtLUlrUko4ZEs3dzF2SlJIQlVRS1pZbDJESDZvMHpFb0FJaVVqSU95NER0S1RoaU5ETzBmR3RMM09JQi1mYThUemROSnhRSzdQcldCLXBWeXpETTJjLUZVMU1pSHFfbVM2alhWV1VRRl9YM0pyelVDNjk4bWJEeGZobzJFME9NRDRtTkxBa3NGRHc?oc=5" target="_blank">New Recommendations Released for Managing Aromatase Inhibitor–Induced Bone Loss</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Extended Aromatase Inhibitor Risk/Benefit
OncLivegeneral

Extended Aromatase Inhibitor Risk/Benefit

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTFBVQWRhTUJIVEwwb01NQ3lQVHhxRWVxQ3ZVWjFXc0daOWVIWHpGMTIxaTY1cE5mTnNmNGx0U0N5WnlmUUUwYXJscHZEeEtDNHNXY1dwcFYxMGJIU3NUYlgwRWpqYndfeExPMkdCYi14dVVzUEgwRHhrR29B?oc=5" target="_blank">Extended Aromatase Inhibitor Risk/Benefit</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
Frontiersworld

Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNa2ZMell0cE5zN0RnbHdUSFl0SnhsWjNlMjY5OHB3UXpYOHVIZ1VTb1laQmhhZENoQ25XYnNVaE1lbG5DZHg2aU1jVW01dWYwRFYwUnBIRnpHVW1uSDFEZFZXb1A2ZUw1c1V4aWlxU1dtZllPV3gwUkVBVkZTTHdmTm5lb0xsOXhMc291UVdn?oc=5" target="_blank">Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy
The Lancetgeneral

Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQcUJCcXFjMDBidzVVbVp1S2VHWU5VcHlBQndtbVBQak9tR0xmNkhFZ2swWndFUU5wUHJBM2ZCbEt2S0U2UE9FaExXZzZwVzVfOFd3TE1tWlRxMmtxd3VSS0RDZ0NuMm1kVTJILUhoRzMyaUF2d3VQLUJYVGczaTRGZnJyUXFkUnZydlIw?oc=5" target="_blank">Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer
ASCO Publicationsgeneral

Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE1Vclk4Z2ZDSjJKNzlYRU5TdXFtMWFSckR2cGZodExicEJEV1FxVGVFUmRFdHJYcm5ROHNuVHZ6YlJ1Nk1JSU9sdFRjSnlMTVpJSkROTVJCdw?oc=5" target="_blank">Personalizing Adjuvant Endocrine Therapy for Early-Stage Hormone Receptor–Positive Breast Cancer</a>  <font color="#6f6f6f">ASCO Publications</font>

Read Full StoryMore like this
Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?
CancerNetworkgeneral

Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?

<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPdERsY0hRRy1TcF9FZGJ1NlZWN3JEN0gyemw2bmdhcHdnaVRBMmdpcFN5OGNkdmkxSU40VnRoZDZldnJfV0N3M2RJVGU1Y2xNMHZJc0d1emdselZSVFNLaG5BbUNiWXJFZGRoc0tOU0FJdDBscVhHOWpBNHhRelpldllMN0FXeXR0eXZDMDVleExyVjVEdTRqb3dBa2dVRkk?oc=5" target="_blank">Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Oestradiol and breast cancer prevention: a 40 year history and contemporary perspective | British Journal of Cancer
Naturegeneral

Oestradiol and breast cancer prevention: a 40 year history and contemporary perspective | British Journal of Cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBNTGlpYTN0M2hKU1ZlWnI2djdOQmY1NHNxbG5fT1BUdUpnRXJvQWJrZWo3bnlKbHhBNnNRUjVjT2MyVG8tWTdmTEc3VjR1SmVxS3N5RlpoaVl0XzEtLUVn?oc=5" target="_blank">Oestradiol and breast cancer prevention: a 40 year history and contemporary perspective | British Journal of Cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Endocrine Therapy Duration in Premenopausal Women With Breast Cancer: Sharing the Decision-Making, Recognizing the Risks
ASCO Daily Newsgeneral

Endocrine Therapy Duration in Premenopausal Women With Breast Cancer: Sharing the Decision-Making, Recognizing the Risks

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOSWgtb1dqVnZhLVpOTE05V3FJS1FCVndFbER0OGRDLXUxcGVmcW9UV0dOLTlfYmlVM3hpR2xmNmdKODUzekpka3lnY3B1SnJpR21mWnFsc1ZfVk12cjVWNmJDM3I0NFVZZmZ6bzdOckU5b0JMaXdyRWdoOHJ2VDBEanZ5bl9wRV8tV0FUTU9OanBCR3MzTjZ0ZVFIZXhfMUJIQjlSMXRoNDRqUWJsOGgyZXhfTGtJQTF4R1E?oc=5" target="_blank">Endocrine Therapy Duration in Premenopausal Women With Breast Cancer: Sharing the Decision-Making, Recognizing the Risks</a>  <font color="#6f6f6f">ASCO Daily News</font>

Read Full StoryMore like this
Ribociclib Plus Nonsteroidal Aromatase Inhibitor Extends iDFS in HR+/HER2– Early-Stage Breast Cancer
OncLivegeneral

Ribociclib Plus Nonsteroidal Aromatase Inhibitor Extends iDFS in HR+/HER2– Early-Stage Breast Cancer

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNVWJxZ3owNlRBSVNsRU5VYlREV1RSOGFVSGhJRlBzcG82dENmWElEUWxFNjdJTXNxTlBVTEhwTi1SNU1fM25wM0RIdnl5ZVVhUTFHRjQxakdQZWJiby1RMW1sZElYZDl0TEE2Ym1KUVFpbHNCX3B1c2pwTTEzak5kVDR3TllxOHdXekZSR0w3NkZna2dZa3puTzBpRzF1M2ZMSXJGMkt0dGZvR3FxdFZJblZJaFd3UmltQ052blR6Z1hBQWhWVEE?oc=5" target="_blank">Ribociclib Plus Nonsteroidal Aromatase Inhibitor Extends iDFS in HR+/HER2– Early-Stage Breast Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Extended Endocrine Therapy in Postmenopausal Women With Breast Cancer: 2 Years as Effective as 5 Years
The ASCO Postgeneral

Extended Endocrine Therapy in Postmenopausal Women With Breast Cancer: 2 Years as Effective as 5 Years

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxONHEzbVZ0OVpLNEVlZEZKR2g2UTZwcWpYWTJfcnBzM1FfYTNvdTFPOXppOGNqcndwOFBZUFRCMC1yM1hCQXVuU3RvQXAwM0VIYWpmT0R1U2ZnWUlxaTlwa2ppMDRkWFJFeFM2UkZkbExESHN3aG84SkxaLTVlN1F5N2VkWWhCV1YxX0FRbWhRWUIzWU5TcEFrVTJXejhhb3hlRlFWb2dJbHlSc2ZmX19CR1dDbnFwOUptbzZIeEVaLS1MSnNSSFpOUkpJZjhMbWhnOXFoTUIzcTJEd0tLbTA0OQ?oc=5" target="_blank">Extended Endocrine Therapy in Postmenopausal Women With Breast Cancer: 2 Years as Effective as 5 Years</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Ribociclib Combo Yields Extended iDFS Benefit in HR+/HER2– Breast Cancer
CancerNetworkgeneral

Ribociclib Combo Yields Extended iDFS Benefit in HR+/HER2– Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQLUMxdml5eDRvanV4UGt5WVdRMG9hVldkNFJ4aWJST3Ztdk9seEtJU2FzMDRtZ3phSm04M090eEJ3cDBaQUUtbU1kY0hnOUs4MFJqZXkyZ3dIVW1zMHpQYm12SVVNM1JFMm5YNWhHVUJySGpjR2owNU5zUXE1Z0hVZHdVQWl6WmZncldLRXdETERYWUVLN3RMOVoyanRMdWRiaXVvTUZuTVU?oc=5" target="_blank">Ribociclib Combo Yields Extended iDFS Benefit in HR+/HER2– Breast Cancer</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
NEJMgeneral

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9fdFkwQjV2QUlYTFVmT1NMTnpHYWZZTWY5bTdHdTBTSmRUVzQ3SWFnZTBOdVpYdHJOdjJCbGk5RXVwc21zTGRJQ1d4VnZjMG9HNUtqTmpNbTNCVVItS0NRSg?oc=5" target="_blank">20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer
The ASCO Postgeneral

Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxQY3lJbWpYWC16OXNvNF9KbGpqRUNDa3dBcVY1bzNpTndVQXlzdjlEZWMteE9lMzhuaDZwZFJNSkdHbnpBQ0ptaDV0LWpYVjhma2d5RC1zTlhBR0lOR1liQ1E2Nm1XU0I4QWNNSnNLcndlanVPUzNYNFBsSnItZTFRUk9heXprM1R1Z2czc0FwNXhmMjlYaGRvR21TSXZ4SmVWbHZOa2NPZ1RFWmlYVkJFM3otdndPYm9RYThBaGhJZnlWUTVOQUlLeGhHSGpzWTduU0RndTEtVGhUUQ?oc=5" target="_blank">Additional 5 Years of Letrozole May Benefit Some Postmenopausal Women With Early-Stage Breast Cancer</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Acupuncture for Joint Symptoms Caused by Aromatase Inhibitors
The ASCO Postworld

Acupuncture for Joint Symptoms Caused by Aromatase Inhibitors

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQOUdpM0FxbGllVHhscTBUNVdzYVhUQWQ0OXhmNjRqZkhUX1dmRFFwWE1GRl9sT2h0bWtEX3AtMThnaVR3dHgydWhoaDlvYVRDTS1WYlMteklWQ0NUWHZCUlRYajNPZVFRSTZhSzdxVU1iNVdTcHU3X0FwUi10RnktZ0hCdXgwVVRyejJ5Ym01Wnhwcjl3SkdqOHlNS1E1R1dLYW1zVjBKQ0RKdlE?oc=5" target="_blank">Acupuncture for Joint Symptoms Caused by Aromatase Inhibitors</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Benefit of Extended Adjuvant Endocrine Therapy Not Upheld in Multiple Studies Reported in San Antonio
The ASCO Postgeneral

Benefit of Extended Adjuvant Endocrine Therapy Not Upheld in Multiple Studies Reported in San Antonio

<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPS3ZVWUtINENOb0kwdllIZFZmRTljcDBPd05kN0VJOG15Wk9ROVNvTFIzRkU2bEMyWXhSRlJIUFlkS0dfNVFqZlFtcllkSENBQ3R5R2FzME1FcWt2LUVyeDFNWm14a3BmTmVDNjB4ckxwalVJcVc5cS1SQmpQcTF4MkdIbV91XzBocVNFcGo4ZGRVNzMzbng4cWlScGowUkpzaWw3N196Nm9RcUpyaTZQSDhkZ2RTOFNqOFRRbk4tN0Vvd3Y0cWlPY1ZwdmJ0eF9qMXJpajVuRS16VF9ZQ3M4cw?oc=5" target="_blank">Benefit of Extended Adjuvant Endocrine Therapy Not Upheld in Multiple Studies Reported in San Antonio</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors
Naturegeneral

A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1fbmt0VDBtY09KUzMzajNXS1Y1N1BVYW05M25sTWI1YXFhaE4xbk9GYzlDOEpWUkZ5OG12eW5oWUtxcnhWOFVxdmNSbXdETmZSSHJXRXkzZVBpWjhEVlZr?oc=5" target="_blank">A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
DFS Benefit Similar With Extended Intermittent or Continuous Letrozole in HR+ Breast Cancer
OncLivegeneral

DFS Benefit Similar With Extended Intermittent or Continuous Letrozole in HR+ Breast Cancer

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOQmREUklVWm4zVHBLSEUwVTYwSlBzS1pzTzN4U2lKN0x5U1ZpMkRrYTJjZGRTakg5dTdxTmhLOTM3V1I5RTZId0ZyckQtY05DTnRIV2lPajludXk0MnhNeEtEa3lnVmRib3V6dkV2SHZHYjdqblBqQUlpbk1XV203OHgyNUt2ekMwNGhBRVNHSGszNlRkbkhLRV82QkoxQ0lSR3NYb281T0RRQlBlYlBaWlBrcWFEMElwclEw?oc=5" target="_blank">DFS Benefit Similar With Extended Intermittent or Continuous Letrozole in HR+ Breast Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
The Lancetgeneral

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxObDE0Sy05bGdnUDN2eEdwMzI2MGdMQzA2Qzk4bV9uSWFxcmVmcHRwZXYwS0xXVXpBd0IxS19QRUdod0RNMlRwTTl4N0cyMVROWkxWYndOdmNJdmxOZldqekdqUDV0V0JlaWdSVTZEaG51V3FsV3pLUTZEamgzYWVKVXh1NVFqSXZYVFY4?oc=5" target="_blank">Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials</a>  <font color="#6f6f6f">The Lancet</font>

Read Full StoryMore like this
Expert Point of View: Harold J. Burstein, MD, and Ian Smith, MD
The ASCO Postgeneral

Expert Point of View: Harold J. Burstein, MD, and Ian Smith, MD

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPeXh4ZmNPMHA1YUVQY3YyNDY3RE9nYVdqMnRFeThzbVNZbnlWMzlLMy1rcWU5NjdKc2F1SzFiQjV1dUJkUjQ5ZWVaYkpHQ1lTcG1HTWtOVWFNdmRKQ1NvQm5DOUtzeE1iQTZpSnFIRzJqZ0MxVlhSdGhLWFM2cmJ4NWh3OWVUd0d6TG5n?oc=5" target="_blank">Expert Point of View: Harold J. Burstein, MD, and Ian Smith, MD</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Effect of adjuvant endocrine therapy: single-agent vs. switching on breast cancer-free and overall survival-a retrospective cohort study
Via Medica Journalsgeneral

Effect of adjuvant endocrine therapy: single-agent vs. switching on breast cancer-free and overall survival-a retrospective cohort study

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE5nQl9TLS1IQnRnUkhjSEpPYmlnRTN1QUVnbFJXcFpHMFVWSUtQcHBzckNWRmMwQUhiZzJYWEhiSncwNDJTLUhQeWVlRjRCelVTbktwRXBNRzd4c19vdXhaWWZ1MDY?oc=5" target="_blank">Effect of adjuvant endocrine therapy: single-agent vs. switching on breast cancer-free and overall survival-a retrospective cohort study</a>  <font color="#6f6f6f">Via Medica Journals</font>

Read Full StoryMore like this
Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks!
professional.heart.orggeneral

Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks!

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxOUEZSVzdkV1BEUTU4WERkN2xENWt1ZHVKaC11cDFDTGM4SkF5UlFpSzBxOHRoaldGYVdBZjBobzJfQWZNOU1fQWJJZ0hVSkxtYWJFeUNQS3B3NU12eGhDRjFSSlhZeFIzMUJRZnVOaTNfWXVsSS01cnZVcjFsUTNOOFdJY29tNGp0QU0zdzJ1eDhsR044dkZpaUZJdjhRWnNuYUlKSWpYTVRTdzNmYzRDNTVWWHh1cmRIaGtyQk1keFRSQlJHOVpqSmNIVUxJR3d6aF9ZcHNHNEk2ejFSdHB1YVc5NkJOOTMxeXQ3Z1ZuMA?oc=5" target="_blank">Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks!</a>  <font color="#6f6f6f">professional.heart.org</font>

Read Full StoryMore like this
Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy
MedPage Todaygeneral

Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE96OXF4cDhqU1JHM2YzQTdoRnc3eXlSUl85N3QybzVoeU5IU0ZLcEM0LWtVa2dqYnpSV2kwS1dCMjFCNGVJY0R2V3dKU1M4UnBhenh5UlUzeUluX3dza29ib2Q5QkRkUmYyRmVJMF9IVmhaUThM?oc=5" target="_blank">Breast Cancer Control Similar With Intermittent, Continuous Endocrine Therapy</a>  <font color="#6f6f6f">MedPage Today</font>

Read Full StoryMore like this
FDA Grants Priority Review to Elinzanetant for Endocrine Therapy–Associated Vasomotor Symptoms in HR+ Breast Cancer
OncLivegeneral

FDA Grants Priority Review to Elinzanetant for Endocrine Therapy–Associated Vasomotor Symptoms in HR+ Breast Cancer

<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQdG8xamRMai1oNjBaQ0tfcjZDdzduNkFjajFiak5wRjFJUHdaRjR1eVBzMklPalhYMElrRnpLYlRYbDdzb282TWUwcXhhMUNWMFpFWl82ekIyaUk2dFBhYUpZVGIxRVY1RUdXRC16bkdNM3k2Uk1GM2JQOVRZa0FETFQ2OVRfQ2NoeTU5U2F5ZENLNlowc19nX2FySXpvaWxZOTdOWFZBazdXX3l2eG1EQlZmLWpZdVFZaS1scExlM3ZDY3dHX0hzTTBJeWpNb0FjenRIQUFqNFc4N1U?oc=5" target="_blank">FDA Grants Priority Review to Elinzanetant for Endocrine Therapy–Associated Vasomotor Symptoms in HR+ Breast Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
ASCO16: Breast cancer recurrence reduced with 10 years of hormone therapy
Oncology Centralgeneral

ASCO16: Breast cancer recurrence reduced with 10 years of hormone therapy

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxPcjNGbFB3SjRHREJCOFh2YVd0X2VjeDI5QV9ZMG1NV1Bqak1idE5QUU5PZWhnWko1N0pnOTFFbmQ2OF9WQnkyMUp3Q0RaVFAyZkd3ZkZXVndtbHFSTTVLR3lFZ0RlUF9DV01YLW1XZFZuaTB0aDFWLUh4UFNDVzVXaUwxSkJLWnlGcGVFaTJjQXIzQVdWRzJkWVlHR2k5bUVnX0E1bUNNUWd0dw?oc=5" target="_blank">ASCO16: Breast cancer recurrence reduced with 10 years of hormone therapy</a>  <font color="#6f6f6f">Oncology Central</font>

Read Full StoryMore like this
Extended Estrogen Suppression Safe in Breast Cancer
Inside Precision Medicinegeneral

Extended Estrogen Suppression Safe in Breast Cancer

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxPTjRidmhja2c4M0VfUFNkM05xSXZDQ2kwLXctVzZNcUl4Q2ZRSEtsMG5CVkFZV1NBdmNBY3BiT2h6UzlsRUkxc2t1TkF1cGoxZGJXTGpzZllhZG45Q3daUGNaWUVwNUF1ejhTazNadU9xWXVpWExzT3FjWG5GZGg1eDQ4ZVlNX3FVRE16dnhIX3ZHczI3aE8zN0pCdjFqREpLLWtqaUp4X0txdzdC?oc=5" target="_blank">Extended Estrogen Suppression Safe in Breast Cancer</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Read Full StoryMore like this
"Extending Aromatase-Inhib" — Live Google News Trends & Headlines